New approaches to filling the gap in tuberculosis drug discovery.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17988169.
- Also identified by PMC identifier 2062479.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
For the first time in decades, say the authors, there is a tuberculosis drug pipeline, but the paucity of candidates is still cause for alarm.
Medical subject headings
- Antitubercular Agents
- Mycobacterium tuberculosis
- Tuberculosis